HPLC Test for Thalassemia and Hb Variants at Dr. Essa Lab

HPLC at Dr. Essa Lab

High-Performance Liquid Chromatography (HPLC) is an advanced, highly precise analytical chemistry technique widely utilized in clinical pathology for the separation, identification, and quantification of various molecular compounds in biological specimens. At Dr. Essa Lab, HPLC is primarily employed as the gold standard diagnostic methodology for hemoglobin variant analysis and thalassemia screening. Hemoglobin is the vital iron-carrying metalloprotein within red blood cells, consisting of globin chains that must be produced in precise ratios. Genetic mutations can disrupt this delicate balance, leading to structural hemoglobin variants or quantitative deficiencies in globin chain synthesis, collectively known as hemoglobinopathies and thalassemias.

The HPLC system operates by introducing a hemolysed whole blood sample into a specialized chromatographic column packed with a charged stationary phase. Under high pressure, a liquid mobile phase of varying ionic strength is pumped through the column. Because different hemoglobin fractions—such as Hemoglobin A (HbA), Hemoglobin A2 (HbA2), and Hemoglobin F (Fetal Hemoglobin)—possess distinct surface charges, they interact uniquely with the stationary phase. This causes them to migrate through the column at different rates, eluting at highly specific retention times. As each fraction exits the column, a spectrophotometer measures its light absorbance at a wavelength of 415 nm. This data is plotted as a chromatogram, displaying distinct peaks that correspond to the percentage of each hemoglobin type present. This high-resolution separation allows the expert pathologists at Dr. Essa Lab to identify even minute structural variations, providing an invaluable diagnostic tool for patients across Karachi and the wider region of Pakistan.

Clinical Procedure: What to Expect

Patient Preparation

• No Fasting Required: Patients do not need to fast before undergoing an HPLC blood test. Dietary intake does not affect hemoglobin structure or concentration.
• Disclose Recent Blood Transfusions: It is absolutely critical to inform the laboratory staff if you have received a blood transfusion within the last 3 to 4 months. Transfused donor red blood cells will temporarily alter your hemoglobin profile, leading to inaccurate or misleading results.
• Provide Medical and Family History: Inform the clinical staff of any family history of thalassemia, sickle cell anemia, or other inherited blood disorders, as this helps pathologists interpret the chromatogram with appropriate clinical context.
• Disclose Iron Deficiency Status: Severe iron deficiency anemia can artificially suppress Hemoglobin A2 (HbA2) levels, potentially masking an underlying beta-thalassemia trait. Inform your physician if you are currently taking iron supplements or have been diagnosed with iron deficiency.
• Stay Well Hydrated: Drinking plenty of water before the test is highly recommended, as proper hydration makes veins more visible and facilitates a smoother venipuncture process.

During the Procedure

• Sanitization and Preparation: A certified phlebotomist at Dr. Essa Lab will begin by verifying your identity and explaining the procedure. They will select a suitable vein, typically in the antecubital fossa of your arm, and cleanse the skin thoroughly with an antiseptic swab.
• Venipuncture: A tourniquet is applied briefly to increase venous pressure, making the vein easier to access. A sterile, single-use needle is gently inserted into the vein to draw the required volume of blood.
• Sample Collection: The blood is collected directly into an EDTA (lavender-top) tube. EDTA acts as an anticoagulant, preserving the integrity of the red blood cells and preventing clotting, which is essential for accurate chromatographic analysis.
• Post-Collection Care: Once the sample is secured, the needle is withdrawn, and a sterile cotton ball is pressed against the puncture site to stop any minor bleeding. A small adhesive bandage is then applied.
• Duration and Sensation: The entire blood collection process is completed in less than five minutes. Patients will feel only a brief, mild pinch as the needle enters the skin.
• Transport and Processing: The collected specimen is immediately labeled with a unique barcode and transported under temperature-controlled conditions to the hematology department, where it is prepared for HPLC analysis.

When is a HPLC Performed?

Screening and Diagnosis of Beta-Thalassemia Trait

Beta-thalassemia is a highly prevalent genetic blood disorder in Pakistan, making carrier detection a major public health priority. Physicians routinely request an HPLC test for individuals with a family history of thalassemia or as part of mandatory premarital screening programs. Identifying beta-thalassemia carriers (thalassemia minor) is crucial, as it allows couples to understand the genetic risk of passing on Beta-Thalassemia Major—a severe, transfusion-dependent condition—to their future children.

Evaluation of Unexplained Microcytic Hypochromic Anemia

When a routine Complete Blood Count (CBC) reveals microcytic hypochromic red blood cells (characterized by low MCV and low MCH), the primary suspect is often iron deficiency. However, thalassemia traits present with virtually identical red cell indices. When iron studies are inconclusive or when microcytic anemia does not respond to iron supplementation, physicians order an HPLC test to evaluate HbA2 and HbF levels, allowing for a definitive differentiation between iron deficiency and a thalassemia trait.

Detection of Sickle Cell Disease and Trait

Sickle cell disease is caused by a structural mutation in the beta-globin chain, resulting in the production of abnormal Hemoglobin S (HbS). This abnormal hemoglobin polymerizes under low oxygen tension, causing red blood cells to assume a rigid, sickle shape that blocks microvasculature. HPLC is highly sensitive and specific in detecting the presence of HbS, allowing clinicians to distinguish between a healthy carrier (Sickle Cell Trait, HbAS) and an individual with active Sickle Cell Disease (HbSS), facilitating early intervention and management.

Antenatal and Prenatal Screening

Obstetricians frequently recommend HPLC testing during early pregnancy as part of routine antenatal care, particularly in regions with a high carrier frequency for hemoglobinopathies. If a pregnant woman is identified as a carrier of thalassemia or an abnormal hemoglobin variant, her partner is immediately screened. If both parents carry a mutation, prenatal diagnostic testing can be performed on the fetus to determine if they have inherited a severe form of the disease, enabling informed clinical decision-making.

Investigation of Unexplained Hemolysis and Splenomegaly

Patients presenting with signs of chronic hemolysis—such as persistent jaundice, dark urine, elevated reticulocyte counts, and physical findings like an enlarged spleen (splenomegaly)—require a comprehensive diagnostic workup. HPLC is performed to identify rare or unstable hemoglobin variants (such as HbE, HbC, or HbD-Punjab) that cause premature red blood cell destruction, helping hematologists establish an accurate diagnosis and tailor an effective treatment strategy.

What Does a HPLC Detect?

The HPLC test is capable of detecting, separating, and quantifying a wide array of normal and abnormal hemoglobin fractions. The primary clinical findings include:

• Normal Hemoglobin A (HbA): The predominant hemoglobin type in healthy adults, typically comprising 95% to 98% of total hemoglobin.
• Elevated Hemoglobin A2 (HbA2): Levels between 3.8% and 8.0% are the definitive diagnostic hallmark of Beta-Thalassemia Trait (Minor).
• Elevated Hemoglobin F (HbF): Markedly high levels of fetal hemoglobin in adults can indicate Hereditary Persistence of Fetal Hemoglobin (HPFH) or Beta-Thalassemia Major.
• Hemoglobin S (HbS): The presence of this peak confirms the sickle cell gene, indicating either sickle cell trait or sickle cell disease depending on its percentage.
• Hemoglobin E (HbE): A common structural variant in Southeast and South Asian populations, which can present as HbE trait or HbE disease.
• Hemoglobin C (HbC): A structural variant that can cause mild hemolytic anemia and splenomegaly when inherited homozygously.
• Hemoglobin D-Punjab: A prevalent hemoglobin variant in the South Asian subcontinent, easily identified by its specific elution time on HPLC.
• Hemoglobin H (HbH): An unstable tetramer of beta-globin chains, indicating Alpha-Thalassemia Intermedia (HbH Disease).
• Double Heterozygosity: Detection of combined states, such as HbS-Beta Thalassemia or HbS-HbC disease.
• Hemoglobin Lepore: A rare fusion hemoglobin variant resulting from unequal crossing over between delta and beta-globin genes.
• Hemoglobin Constant Spring: An abnormally long alpha-chain variant that causes mild alpha-thalassemia-like symptoms.
• Hemoglobin G-Philadelphia: A benign alpha-chain variant that elutes in a characteristic position on the chromatogram.
• Hemoglobin O-Arab: A rare beta-chain variant that can cause severe hemolytic anemia when co-inherited with HbS or beta-thalassemia.
• Hemoglobin Hope: A clinically silent variant that can occasionally interfere with other diagnostic assays like HbA1c.
• Hemoglobin Camden: A benign, non-pathological beta-chain variant detected incidentally during routine screening.
• Hemoglobin Q-India: An alpha-chain variant commonly found in the Indian subcontinent, usually clinically silent in heterozygous individuals.
• Decreased Hemoglobin A2 (HbA2): Levels below 1.5% can indicate severe iron deficiency anemia, lead poisoning, or certain forms of alpha-thalassemia.
• Presence of Degraded Sample Peaks: Indicates sample instability or delay in processing, requiring a repeat collection.
• Baseline Noise: Can occur due to severe hyperlipidemia or hyperbilirubinemia, which may interfere with optical detection.
• Post-Transfusion Normalization: A normal chromatogram in a known thalassemia patient due to recent donor blood transfusion, masking the native pathology.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we prioritize both diagnostic accuracy and efficiency. HPLC testing is performed using state-of-the-art, fully automated chromatography platforms that are calibrated daily to ensure the highest level of precision. Once the sample is processed, the resulting chromatogram is meticulously reviewed and verified by our team of consultant hematologists and pathologists.

The typical turnaround time for an HPLC test at Dr. Essa Lab is 24 to 48 hours from the time of sample collection. To make the process as convenient as possible for our patients, reports can be accessed and downloaded digitally through the official Dr. Essa Lab website or our dedicated mobile application. Patients will receive an automated SMS notification containing a secure link to download their report as soon as it is finalized. Physical reports can also be collected from any of our diagnostic centers across Karachi and other major cities.

HPLC Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Hemoglobin A (HbA)	95.0% – 98.0%	Decreased or absent in Beta-Thalassemia Major, Sickle Cell Disease, and HbE Disease.
Hemoglobin A2 (HbA2)	1.5% – 3.5%	Elevated (3.8% – 8.0%) in Beta-Thalassemia Trait; Decreased (<1.5%) in severe iron deficiency or Alpha-Thalassemia.
Hemoglobin F (HbF)	< 1.0% (in adults)	Elevated in Beta-Thalassemia Major, HPFH, Sickle Cell Anemia, and during pregnancy.
Hemoglobin S (HbS)	Absent (0.0%)	Present in Sickle Cell Trait (30%-45%) and Sickle Cell Disease (>80%).
Hemoglobin E (HbE)	Absent (0.0%)	Present in Hemoglobin E Trait, HbE Disease, or HbE-Beta Thalassemia.
Hemoglobin C (HbC)	Absent (0.0%)	Present in Hemoglobin C Trait or Hemoglobin C Disease.
Hemoglobin D-Punjab	Absent (0.0%)	Present in Hemoglobin D Trait or Hemoglobin D Disease.
Chromatographic Baseline	Clean, stable baseline	Presence of unknown variant peaks or baseline noise due to lipemia or sample degradation.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for HPLC?

• Pioneering Diagnostic Excellence: Established in 1987 by Prof. Dr. Essa Abdulla, Dr. Essa Lab is one of Pakistan’s most trusted and recognized diagnostic networks.
• Advanced HPLC Technology: We utilize state-of-the-art, fully automated chromatography systems that ensure high-resolution separation and precise quantification of hemoglobin fractions.
• Expert Pathologists and Hematologists: Every abnormal HPLC chromatogram is thoroughly reviewed and interpreted by highly qualified consultant hematologists.
• Strict Quality Control: Our laboratories adhere to international standards of quality assurance, participating in rigorous external quality control programs.
• Extensive Network: With numerous collection points across Karachi and other major cities, accessing our diagnostic services is convenient and hassle-free.
• Seamless Digital Integration: Patients can easily view, download, and share their HPLC reports online via our secure web portal or mobile app.
• Compassionate Patient Care: Our highly trained phlebotomists ensure a gentle, safe, and comfortable blood collection experience for patients of all ages, including infants.
• Affordable and Transparent Pricing: We offer competitive pricing for specialized tests like HPLC, making critical genetic screening accessible to all segments of society.